一般演題口演 CKD English

[O-255] Cardiorenal Events in Medication-Initiator Cohorts of Patients with Chronic Kidney Disease and Type 2 Diabetes in Japan

^○Naoki Kashihara¹, Hiroshi Kanegae², Suguru Okami³, Kanae Yoshikawa-Ryan³, Nikolaus G Oberprieler⁴, Manel Pladevall-Vila⁵, J Bradley Layton⁶, Satoshi Yamashita³, Catherine Johannes⁷, Alredo E. Farjat⁸, Csaba P. Kovesdy⁹, David Vizcaya⁴, Yuichiro Yano¹⁰ (1.Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan, 2.Genki Plaza Medical Center for Health Care, Office of Research and Analysis, Tokyo, Japan, 3.Bayer Yakuhin Ltd., Medical Affairs ＆ Pharmacovigilance, Osaka, Japan, 4.Integrated Evidence Generation ＆ Business Innovation, Bayer AG, 13342 Berlin, Germany, 5.RTI Health Solutions, Pharmacoepidemiology and risk management, Barcelona, Spain, 6.RTI Health Solutions, Pharmacoepidemiology and risk management, Research Triangle Park NC, USA, 7.RTI Health Solutions, Pharmacoepidemiology and risk management, Waltham MA, USA, 8.Bayer PLC, Statistics ＆ Data Insights, Reading, United Kingdom, 9.University of Tennessee, Health Science Center, Department of Medicine, Memphis TN, USA, 10.Shiga University of Medical Science, Department of Advanced Epidemiology NCD Epidemiology Research Center, Otsu, Japan)